🔎 Trials Near Me

Akèy › Maladi kadyovaskilè › Oklahoma › Oklahoma City

Etid klinik pou Maladi kadyovaskilè nan Oklahoma City, OK

8 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Ap rekriteFaz 4
  • South Oklahoma Heart Research, LLC, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06909565

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Tekton Research Oklahoma City, Oklahoma City
  • South Oklahoma Heart Research Group, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Ap rekriteFaz 3
  • Clinical Trial Site, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Ap rekrite
  • Integris Baptist Medical Center, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT03242642

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Ap rekrite
  • Integris Baptist Medical Center, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

Ap rekrite
  • University of Oklahoma Health Science Center, Oklahoma City
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2025 · NCT06271590

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Ap rekrite
  • Oklahoma University Health (OU Health), Oklahoma City
Laj 18 a 110 · Tout sèks · Mizajou Feb 25, 2025 · NCT05908331

Etid Maladi kadyovaskilè nan lòt vil

Lòt etid nan Oklahoma City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.